GPT and metabolic dysfunction-associated steatotic liver disease: Previously published ALT level/NAFLD risk-associated variants with genome-wide significance and associations with advanced fibrosis/cirrhosis and platelet count at enrollment among patients with NAFLD (n = 60,542).